Joanne Berger-Sweeney

Joanne E. Berger-Sweeney is an American neuroscientist and the 22nd president of Trinity College, Hartford, Connecticut. She is the first African-American and the first woman to serve in the position. Earlier in her career, Berger-Sweeney did proof-of-concept work on galantamine, the second-most used drug to treat Alzheimer's disease.